Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Gynecologic 3Tumor-Agnostic 2Thoracic 2Head & Neck 2Genitourinary 2Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1CNS 1

Conditions

Neoplasms 1Multiple Myeloma 1Emotional Regulation 1

Interventions

Dexamethasone 479Lenalidomide 297Cyclophosphamide 271Bortezomib 267Melphalan 212Calcium Dobesilate 189daratumumab 122fludarabine phosphate 121Peripheral Blood Stem Cell Transplantation 101fludarabine 99carfilzomib 98Thalidomide 94pomalidomide 92Filgrastim 92Whole-Body Irradiation 88Mycophenolic Acid 88Busulfan 80Tacrolimus 75Granulocyte Colony-Stimulating Factor 72dexamethasone acetate 65ixazomib 62Cyclosporine 59dexamethasone 21-phosphate 56Antilymphocyte Serum 51auricularum 50isatuximab 44Radiotherapy 41Etoposide 40Stem Cell Transplantation 39Methotrexate 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Population Groups × Plasma cell × Clear all
NCT07236021 2025-11-21

e-Motion : Promoting Emotion Regulation in Chronic Cancer

Université Libre de Bruxelles

Phase NA Recruiting
30 enrolled
Plasma cell

Emotional Regulation, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡